Autophagy gene ATG16L1 influences susceptibility and disease location but not childhood-onset in Crohn's disease in northern Europe

Inflammatory Bowel Diseases

Volumn 14, Issue 3, 2008, Pages 338-346

  Van Limbergen, Johan ^a,b   Russell, R K ^c   Nimmo, E R ^a   Drummond, H E ^a   Smith, L ^a   Anderson, N H ^a   Davies, G ^a   Gillett, P M ^b   McGrogan, P ^c   Weaver, L T ^d   Bisset, W M ^e   Mahdi, G ^e   Arnott, I D ^a   Wilson, D C ^a,b   Satsangi, J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^c ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e ROYAL ABERDEEN CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

ATG16L1; Autophagy; Crohn's disease; Genetics; Inflammatory bowel disease; Pediatrics

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15;

ADOLESCENT; ADULT; ALLELE; ANALYSIS OF VARIANCE; ARTICLE; ATG16L1 GENE; AUTOPHAGY; BODY HEIGHT; BODY MASS; BODY WEIGHT; CASE CONTROL STUDY; CHILDHOOD; COHORT ANALYSIS; COLON DISEASE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; GENE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GERM LINE; HUMAN; ILEUM DISEASE; KRUSKAL WALLIS TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; ONSET AGE; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE OF ONSET; ALLELES; CARRIER PROTEINS; CASE-CONTROL STUDIES; CHILD; CROHN DISEASE; DNA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NOD2 SIGNALING ADAPTOR PROTEIN; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; SCOTLAND;

EID: 41149137717     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20340     Document Type: Article

References (49)

1. Griffiths AM. Specificities of inflammatory bowel disease in childhood. Best Pract Res Clin Gastroenterol. 2004;18:509-523.
2. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448:427-434.
3. Rioux JD, Xavier RJ, Taylor KD, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet. 2007;39:596-604.
4. Raelson JV, Little RD, Ruether A, et al. From the cover: genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci. Proc Natl Acad Sci U S A. 2007;104:14747-14752.
5. Franke A, Hampe J, Rosenstiel P, et al. Systematic association mapping identifies NELL1 as a novel IBD disease gene. PLos ONE. 2007;2:e691.
6. Hampe J, Franke A, Rosenstiel P, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet. 2007;39:207-211.
7. Libioulle C, Louis E, Hansoul S, et al. A novel susceptibility locus for Crohn's disease identified by whole genome association maps to a gene desert on chromosome 5p13.1 and modulates the level of expression of the prostaglandin receptor EP4. PloS Genet. 2007;3:e58.
8. Parkes M, Barrett JC, Prescott NJ, et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet. 2007;39:830-832.
9. Duerr RH. Genome-wide association studies herald a new era of rapid discoveries in inflammatory bowel disease research. Gastroenterology. 2007;132:2045-2049.
10. Van Limbergen J, Russell RK, Nimmo ER, et al. The genetics of inflammatory bowel disease. Am J Gastroenterol. 2007 e-pub 25/9/07; doi: 10.1111/j.1572-0241.2007.01527.x
11. Schmid D, Dengjel J, Schoor O, et al. Autophagy in innate and adaptive immunity against intracellular pathogens. J Mol Med. 2006;84:194-202.
12. Birmingham CL, Smith AC, Bakowski MA, et al. Autophagy controls salmonella infection in response to damage to the salmonella-containing vacuole. J Biol Chem. 2006;281:11374-11383.
13. Birmingham CL, Canadien V, Gouin E, et al. Listeria monocytogenes evades killing by autophagy during colonization of host cells. Autophagy. 2007;3:442-451.
14. Suzuki T, Franchi L, Toma C, et al. Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella.- infected macrophages. PLoS Pathogens. 2007;3:e111.
15. Gutierrez MG, Master SS, Singh SB, et al. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell. 2004;119:753-766.
16. Baldassano RN, Bradfield JP, Monos DS, et al. Association of the T300A non-synonymous variant of the ATG16L1 gene with susceptibility to paediatric Crohn's disease. Gut. 2007;56:1171-1173.
17. Prescott NJ, Fisher SA, Franke A, et al. A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5. Gastroenterology. 2007;132:1665-1671.
18. Cummings JFR, Cooney R, Pathan S, et al. Confirmation of the role of ATG16L1 as a Crohn's disease susceptibility gene. Inflamm Bowel Dis. 2007;13:941-946.
19. Sawczenko A, Sandhu BK, Logan RFA, et al. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet. 2001;357:1093-1094.
20. Hait E, Bousvaros A, Grand R. Pediatric inflammatory bowel disease: what children can teach adults. Inflamm Bowel Dis. 2005;11:519-527.
21. Russell RK, Van Limbergen JE, Drummond HE, et al. Disease phenotype but not genotype differs in children and adults with inflammatory bowel disease at diagnosis: analysis of more than 1500 patients from a homogenous patient cohort. J Pediatr Gastroenterol Nutr. 2007;44:e1-e360.
22. Russell RK, Drummond HE, Nimmo ER, et al. Genotype-phenotype analysis in childhood-onset Crohn's disease: NOD2/CARD15 variants consistently predict phenotypic characteristics of severe disease. Inflamm Bowel Dis. 2005;11:955-964.
23. Russell RK, Drummond HE, Nimmo ER, et al. Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease. Gut. 2006;55:1114-1123.
24. Van Limbergen JE, Russell RK, Nimmo ER, et al. IL23R Arg381Gln is associated with childhood onset inflammatory bowel disease in Scotland. Gut. 2007;56:1173-1174.
25. Arnott IDR, Nimmo ER, Drummond HE, et al. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe? Genes Immun. 2004; 5:417-425.
26. Noble CL, Nimmo ER, Drummond H, et al. The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease. Gastroenterology. 2005;129:1854-1864.
27. Tremelling M, Cummings F, Fisher SA, et al. IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease. Gastroenterology. 2007;132:1657-1664.
28. Noble CL, Nimmo ER, Drummond H, et al. DLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish population. Gut. 2005;54:1416-1420.
29. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol. 1989;24:2-6.
30. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5A-36A.
31. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
32. The International HapMap Consortium. A haplotype map of the human genome. Nature. 2005;437:1299-1320.
33. Laird N, Horvath S, Xu X. Implementing a unified approach to family based tests of association. Genet Epidemiol. 2000;19:S36-S42.
34. Gauderman WJ. Candidate gene association studies for a quantitative trait, using parent-offspring trios. Genet Epidemiol. 2003;25:327-338.
35. Gauderman WJ, Morrison JM. QUANTO 1.1: a computer program for power and sample size calculations for genetic epidemiology studies. 2006.
36. Armitage E, Drummond HE, Wilson DC, et al. Increasing incidence of both juvenile-onset Crohn's disease and ulcerative colitis in Scotland. Eur J Gastroenterol Hepatol. 2001;13:1439-1447.
37. Stone MA, Mayberry JF, Baker R. Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England. Eur J Gastroenterol Hepatol. 2003;15:1275-1280.
38. Gaya DR, Russell RK, Nimmo ER, et al. New genes in inflammatory bowel disease: lessons for complex diseases? Lancet. 2006;367:1271-1284.
39. Riis L, Vind I, Vermeire S, et al. The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients. Inflamm Bowel Dis. 2007;13:24-32.
40. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447:661-678.
41. Balde M, Vernier-Massouille G, Gower-Rousseau C, et al. Natural history of Crohn's disease in children: a population-based cohort study in Northern France. J Pediatr Gastroenterol Nutr. 2006;42:E25.
42. Hildebrand H, Finkel Y, Grahnquist L, et al. Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990-2001. Gut. 2003;52:1432-1434.
43. Freeman HJ. Application of the Montreal classification for Crohn's disease to a single clinician database of 1015 patients. Can J Gastroenterol. 2007;21:363-366.
44. Escher JC, IBD Working Group of the European Society for Paediatric Gastroenterology HaN. First European database of pediatric inflammatory bowel disease (IBD). J Pediatr Gastroenterol Nutr. 2006;42:E25.
45. Paul TM, Birnbaum AM, Pal DKP, et al. Distinct phenotype of early childhood inflammatory bowel disease. J Clin Gastroenterol. 2006;40:583-586.
46. Heyman MB, Kirschner BS, Gold BD, et al. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr. 2005;146:35-40.
47. Gearry RB, Roberts RL, Burt MJ, et al. Effect of inflammatory bowel disease classification changes on NOD2 genotype-phenotype associations in a population-based cohort. Inflamm Bowel Dis. 2007;13:1220-1227.
48. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411:599-603.
49. Silverberg MS, Duerr RH, Brant SR, et al. Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease. Eur J Hum Genet. 2007;15:328-335.